Development of UV Spectrophotometric Methods for the Determination of Risedronate Sodium in Different Solutions

被引:1
作者
Abdali, T. [1 ]
Hasian, J. [1 ]
机构
[1] Univ Damascus, Dept Ind Pharm & Pharmaceut Technol, Fac Pharm, Damascus, Syria
关键词
risedronate sodium; spectrophotometry; validation; OSTEOPOROSIS; VALIDATION;
D O I
10.1007/s10812-021-01282-5
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Four simple, low-cost, sensitive, accurate, and direct spectrophotometric methods for risedronate sodium (RIS) estimation have been developed. All methods were based on pyridinyl sensitivity for the UV light at 262 nm. The proposed methods were extensively validated according to the ICH guidelines and proved as following Beer's law over the concentration ranges 6-120, 5-100, 17-170, and 15-150 mu g/mL for methods 1, 2, 3, and 4, respectively. All the proposed methods were found to be precise with RSD values less than 2% and accurate with recovery values between 90-110%. These methods can fully fill the needs of QC routine tests plus meet different demands for Research and Development departments.
引用
收藏
页码:1076 / 1080
页数:5
相关论文
共 12 条
  • [1] Alarfaj NA, 2011, ASIAN J CHEM, V23, P697
  • [2] Stabifity indicating ion-pair HPLC method for the determination of risedronate in a commercial formulation
    Aluoch, A
    Tatini, R
    Parsons, DM
    Sadik, O
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2004, 27 (17) : 2799 - 2813
  • [3] [Anonymous], 1995, INT C HARM GUID IND
  • [4] Successive advanced oxidation of pyridine by ultrasonic irradiation: effect of additives and kinetic study
    Elsayed, M. A.
    [J]. DESALINATION AND WATER TREATMENT, 2015, 53 (01) : 57 - 65
  • [5] The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data
    Gu, Jie-mei
    Wang, Li
    Lin, Hua
    Chen, De-cai
    Tang, Hai
    Jin, Xiao-lan
    Xia, Wei-bo
    Hu, Yun-qiu
    Fu, Wen-zhen
    He, Jin-wei
    Zhang, Hao
    Wang, Chun
    Yue, Hua
    Hu, Wei-wei
    Liu, Yu-juan
    Zhang, Zhen-lin
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (07) : 841 - 846
  • [6] Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations
    Kyriakides, Dernetra
    Panderi, Irene
    [J]. ANALYTICA CHIMICA ACTA, 2007, 584 (01) : 153 - 159
  • [7] 7 Bisphosphonates for the treatment of osteoporosis: insights for clinicians
    Lewiecki, E. Michael
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2010, 1 (03) : 115 - 128
  • [8] DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING CAPILLARY ELECTROPHORESIS METHOD FOR THE DETERMINATION OF RISEDRONATE IN TABLETS
    Sun, Li
    Wan, Shuxin
    Liang, Qinggang
    Tan, Fengping
    Li, Nan
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2013, 36 (08) : 1054 - 1067
  • [9] Spectrophotometric determination of some drugs for osteoporosis
    Taha, EA
    Youssef, NF
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (12) : 1444 - 1447
  • [10] Ugurlu G, 2008, REV ANAL CHEM, V27, P215